AMV564-301
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Amphivena Therapeutics
Start Date
June 4, 2020
End Date
July 5, 2025
Administered By
Duke Cancer Institute
Awarded By
Amphivena Therapeutics
Start Date
June 4, 2020
End Date
July 5, 2025